Inspire Medical Systems (INSP) Competitors $127.70 -0.30 (-0.23%) As of 01:01 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock INSP vs. SOLV, SNN, PEN, STVN, GKOS, BLCO, NARI, IRTC, SLNO, and TMDXShould you be buying Inspire Medical Systems stock or one of its competitors? The main competitors of Inspire Medical Systems include Solventum (SOLV), Smith & Nephew SNATS (SNN), Penumbra (PEN), Stevanato Group (STVN), Glaukos (GKOS), Bausch + Lomb (BLCO), Inari Medical (NARI), iRhythm Technologies (IRTC), Soleno Therapeutics (SLNO), and TransMedics Group (TMDX). These companies are all part of the "medical equipment" industry. Inspire Medical Systems vs. Its Competitors Solventum Smith & Nephew SNATS Penumbra Stevanato Group Glaukos Bausch + Lomb Inari Medical iRhythm Technologies Soleno Therapeutics TransMedics Group Solventum (NYSE:SOLV) and Inspire Medical Systems (NYSE:INSP) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, earnings, dividends, media sentiment, profitability, risk, institutional ownership and analyst recommendations. Do analysts prefer SOLV or INSP? Solventum presently has a consensus price target of $84.38, suggesting a potential upside of 15.75%. Inspire Medical Systems has a consensus price target of $210.27, suggesting a potential upside of 64.66%. Given Inspire Medical Systems' stronger consensus rating and higher possible upside, analysts plainly believe Inspire Medical Systems is more favorable than Solventum.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Solventum 1 Sell rating(s) 6 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.27Inspire Medical Systems 0 Sell rating(s) 3 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.73 Do insiders & institutionals hold more shares of SOLV or INSP? 94.9% of Inspire Medical Systems shares are owned by institutional investors. 0.1% of Solventum shares are owned by company insiders. Comparatively, 4.1% of Inspire Medical Systems shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Which has preferable valuation and earnings, SOLV or INSP? Solventum has higher revenue and earnings than Inspire Medical Systems. Solventum is trading at a lower price-to-earnings ratio than Inspire Medical Systems, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSolventum$8.31B1.52$478M$2.1633.75Inspire Medical Systems$840.11M4.48$53.51M$2.1758.85 Is SOLV or INSP more profitable? Inspire Medical Systems has a net margin of 7.92% compared to Solventum's net margin of 4.55%. Solventum's return on equity of 31.01% beat Inspire Medical Systems' return on equity.Company Net Margins Return on Equity Return on Assets Solventum4.55% 31.01% 6.53% Inspire Medical Systems 7.92%10.00%8.68% Does the media prefer SOLV or INSP? In the previous week, Inspire Medical Systems had 3 more articles in the media than Solventum. MarketBeat recorded 12 mentions for Inspire Medical Systems and 9 mentions for Solventum. Inspire Medical Systems' average media sentiment score of 1.21 beat Solventum's score of 0.87 indicating that Inspire Medical Systems is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Solventum 3 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Inspire Medical Systems 10 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more volatility & risk, SOLV or INSP? Solventum has a beta of 0.55, indicating that its share price is 45% less volatile than the S&P 500. Comparatively, Inspire Medical Systems has a beta of 1.25, indicating that its share price is 25% more volatile than the S&P 500. SummaryInspire Medical Systems beats Solventum on 13 of the 16 factors compared between the two stocks. Get Inspire Medical Systems News Delivered to You Automatically Sign up to receive the latest news and ratings for INSP and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding INSP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart INSP vs. The Competition Export to ExcelMetricInspire Medical SystemsMEDICAL INFO SYS IndustryMedical SectorNYSE ExchangeMarket Cap$3.78B$1.98B$5.56B$20.60BDividend YieldN/AN/A4.23%3.65%P/E Ratio59.0034.1528.6127.20Price / Sales4.4814.98437.4953.52Price / Cash76.2454.7436.0222.28Price / Book5.558.558.184.58Net Income$53.51M-$62.39M$3.23B$995.22M7 Day Performance-5.06%-2.01%-0.25%-1.09%1 Month Performance-1.52%10.04%5.40%3.25%1 Year Performance-12.46%3.57%26.35%6.97% Inspire Medical Systems Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)INSPInspire Medical Systems4.8604 of 5 stars$127.70-0.2%$210.27+64.7%-7.8%$3.78B$840.11M59.001,246Positive NewsAnalyst ForecastSOLVSolventum0.7261 of 5 stars$76.24-2.9%$81.50+6.9%+52.8%$13.19B$8.25B35.3022,000Analyst UpgradeSNNSmith & Nephew SNATS2.8871 of 5 stars$29.95-1.1%$28.00-6.5%+5.9%$13.12B$5.81B13.8717,349PENPenumbra4.7324 of 5 stars$248.05-1.2%$302.40+21.9%+23.4%$9.61B$1.19B234.014,500STVNStevanato GroupN/A€24.23-1.5%N/A+21.0%€7.34B€1.19B47.515,521Positive NewsGKOSGlaukos4.3297 of 5 stars$101.69-1.7%$134.67+32.4%-20.2%$5.81B$383.48M-42.91780Analyst ForecastBLCOBausch + Lomb3.0186 of 5 stars$13.83-0.4%$15.54+12.4%-13.4%$4.89B$4.83B-13.4313,500NARIInari Medical0.2615 of 5 stars$79.97flat$69.22-13.4%N/A$4.68B$493.63M-59.24800IRTCiRhythm Technologies1.0119 of 5 stars$139.22-2.3%$138.60-0.4%+35.8%$4.44B$591.84M-44.342,000Analyst ForecastSLNOSoleno Therapeutics4.5825 of 5 stars$85.27-1.6%$107.10+25.6%+66.5%$4.30BN/A-18.4630TMDXTransMedics Group2.2529 of 5 stars$125.17-3.1%$127.33+1.7%-19.9%$4.23B$441.54M92.04210Positive NewsAnalyst Forecast Related Companies and Tools Related Companies Solventum Alternatives Smith & Nephew SNATS Alternatives Penumbra Alternatives Stevanato Group Alternatives Glaukos Alternatives Bausch + Lomb Alternatives Inari Medical Alternatives iRhythm Technologies Alternatives Soleno Therapeutics Alternatives TransMedics Group Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:INSP) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredRevolutionary AI Tech Targets Early Diabetic Blindness Detection FDA Trial UnderwayTiny Stock, Massive Potential— this company’s AI platform is a game changer for healthcare!Interactive Offers | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredCentral Banks Are Hoarding Gold – Should You?The AI boom isn’t just transforming technology—it’s redefining global power, increasing government debt, and u...Lear Capital | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredAll New Social Security Numbers coming July 23?To All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | Sponsored"Death Spiral" Threatening Your SavingsThe "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…GoldCo Precious Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Inspire Medical Systems, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Inspire Medical Systems With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
